Bernie Sanders opened a hearing with Big Pharma CEOs by acknowledging “the many Americans who have needlessly lost their lives because of the unaffordability of insulin.”
Only federal legislation of this sort can “put an end to decades of price gouging that has led to preventable suffering and costs the lives of people with diabetes who need insulin to live,” Knievel emphasized.
If Novo Nordisk can lower the price of Novolog by 75%, why is it still charging Americans with diabetes $12,000 for Ozempic when the exact same drug can be purchased for just $2,000 in Canada? “We want to know why there are Americans who are dying, or are becoming much sicker than they should, because they can’t afford the medicine they need,” he continued.
In Sanders’ words, “That could well explain why we pay the highest prices for prescription drugs in the world and why today drug companies can set the price of new drugs at any level they wish.”
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Sanders Grills Big Pharma CEOs Over Years of Deadly Price Gouging'We want to know why there are Americans who are dying, or are becoming much sicker than they should, because they can't afford the medicine they need,' said the Vermont Independent.
Les mer »
Pharma CEOs to testify in Senate hearing on insulin pricesThe leaders of major insulin makers and pharmacy benefit managers are set to point to causes of issues on Wednesday in their testimonies during a Senate committee hearing on making the life-saving drug more affordable.
Les mer »
Pharma CEOs play insulin price blame game during bipartisan Senate grillingCEOs from leading pharmaceutical companies and pharmacy benefit managers spent three hours before a leading Senate committee pointing fingers at one another as the party responsible for high insulin prices.
Les mer »
Rocky Mountain resorts set record for skier visits for second consecutive seasonNSAA, which is headquartered in Lakewood, put the cumulative number at 64.7 million, a 6.6% increase over last year
Les mer »
Feds turn antitrust focus to digital pharma adsThe investigation into health data giant IQVIA’s ad tech deal focuses on harm to rivals and increased costs for drugmakers.
Les mer »
Firm founded by ‘Pharma Bro’ Martin Shkreli files for bankruptcyShkreli even directed Vyera to continue anticompetitive actions while he was serving a prison sentence on securities fraud charges, Vyera said.
Les mer »